POINT Biopharma Global
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
BVF PARTNERS L P/IL
Common Stock, $0.0001 par value 896,366 $12.45 $11,159,757
Option
HOGUE GERALD L. director
 Stock Option (Right to Buy) 17,936 $6.97 $125,014
Option
HOGUE GERALD L. director
 Common Stock 17,936 $6.97 $125,014
Purchase
MCCANN JOE A. director, officer: Chief Execut..
 Common Stock 2,160 $6.64 $14,342
Purchase
MALIK RAJESH director
 Common Stock 3,700 $6.66 $24,642
Purchase
HOGUE GERALD L. director
 Common Stock 3,660 $6.82 $24,943
Purchase
LUBNER DAVID CHARLES director
 Common Stock 3,600 $6.85 $24,660
Purchase
MARGOLIN YAEL director
 Common Stock 1,710 $6.56 $11,218
Purchase
GOODMAN JONATHAN R. director
 Common Stock 6,000 $6.33 $37,980
Purchase
SILBER ALLAN C director, 10 percent owner, off..
 Common Stock 22,397 $6.5 $145,581
Purchase
SILBER ALLAN C director, 10 percent owner, off..
 Common Stock 27,603 $6 $165,618
Sale
FLESHNER NEIL E. director, officer: Chief Medica..
 Common Stock 564,204 $7.51 $4,237,172
Purchase
RA CAPITAL MANAGEMENT, L.P. director
 Common Stock 209,100 $10 $2,091,000

Showing 1 to 13 of 13 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: